New blood test detects more high-risk prostate cancer cases

AI Summary

A new blood test, Stockholm3, developed by Karolinska Institutet, detects high-risk prostate cancer cases more effectively than the traditional PSA test without increasing unnecessary testing, according to a study published in the Annals of Internal Medicine.

A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically significant cancer cases than the PSA test, without subjecting more men to unnecessary testing. The study is published in the Annals of Internal Medicine.